UWM Holdings Corporation (UWMC) concluded trading on Wednesday at a closing price of $4.19, with 5.19 million shares of worth about $21.75 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -30.40% during that period and on Wednesday the price saw a gain of about 2.20%. Currently the company’s common shares owned by public are about 200.78M shares, out of which, 140.46M shares are available for trading.
Stock saw a price change of -1.18% in past 5 days and over the past one month there was a price change of -8.32%. Year-to-date (YTD), UWMC shares are showing a performance of -28.62% which decreased to -39.71% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.88 but also hit the highest price of $9.74 during that period. The average intraday trading volume for UWM Holdings Corporation shares is 5.16 million. The stock is currently trading -2.15% below its 20-day simple moving average (SMA20), while that difference is down -12.17% for SMA50 and it goes to -34.70% lower than SMA200.
UWM Holdings Corporation (NYSE: UWMC) currently have 200.78M outstanding shares and institutions hold larger chunk of about 57.38% of that.
The stock has a current market capitalization of $6.70B and its 3Y-monthly beta is at 1.73. It has posted earnings per share of -$0.15 in the same period. It has a debt-to-equity ratio of 70.19. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for UWMC, volatility over the week remained 1.99% while standing at 4.44% over the month. Stock’s fiscal year EPS is expected to rise by 53.82% while it is estimated to increase by 95.59% in next year.
Coverage by Morgan Stanley stated UWM Holdings Corporation (UWMC) stock as an Overweight in their note to investors on April 07, 2025, suggesting a price target of $6.50 for the stock. On March 03, 2025, Keefe Bruyette Upgrade their recommendations, while on November 05, 2024, Morgan Stanley Resumed their ratings for the stock with a price target of $7.50. Stock get an Equal weight rating from Barclays on October 08, 2024.
